Regeneron Pharmaceuticals Inc
Stock Chart, Company Information, and Scan Results
$686.36(as of Apr 29, 4:00 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Regeneron Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$686.36
Ticker SymbolREGN
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees15,410
CountyUSA
Market Cap$76,718.1M
EBIDTA4,245.7M
10-Day Moving Average742.01
P/E Ratio16.38
20-Day Moving Average751.53
Forward P/E Ratio17.30
50-Day Moving Average758.88
Earnings per Share41.49
200-Day Moving Average681.04
Profit Margin21.74%
RSI29.32
Shares Outstanding103.0M
ATR22.10
52-Week High820.12
Volume1,833,500
52-Week Low474.60
Book Value31,256.9M
P/B Ratio2.36
Upper Keltner801.27
P/S Ratio5.14
Lower Keltner701.80
Debt-to-Equity Ratio801.27
Next Earnings DateUnknown
Cash Surplus-1,250.3M
Next Ex-Dividend DateUnknown
Looking for a prescription for success? Then this could be the stock for you. Regeneron is at the forefront of biotechnology that develops and commercializes life-transforming medicines. They are best known for their blockbuster drug Eylea, which is used to treat age-related macular degeneration—a leading cause of blindness in the elderly.
Regeneron Pharmaceuticals Inc In Our Stock Scanner
As of Apr 30, 2026
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
Scan Name: Oversold Stocks Scan Type: Stock Indicator Scans
As of ---
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---
Scan Name: Earnings AnnouncementsScan Type: Stock Fundamentals
As of ---
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.